ST Wuhan National Pharmaceuticals Co., Ltd. provided earnings guidance for the year 2013. The company predicts that its net profit owned by shareholders of listed company in 2013 will be about between RMB 11 million and RMB 15 million, with a predicted year-on-year decrease of above 80% in business performance. The net profit belonging to shareholders of the listed company is positive at the end of 2013.